167 related articles for article (PubMed ID: 38077210)
41. Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma.
Wu F; Li GZ; Liu HJ; Zhao Z; Chai RC; Liu YQ; Jiang HY; Zhai Y; Feng YM; Li RP; Zhang W
J Pathol; 2020 Jul; 251(3):272-283. PubMed ID: 32418210
[TBL] [Abstract][Full Text] [Related]
42. High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts.
Roux A; Pallud J; Saffroy R; Edjlali-Goujon M; Debily MA; Boddaert N; Sanson M; Puget S; Knafo S; Adam C; Faillot T; Cazals-Hatem D; Mandonnet E; Polivka M; Dorfmüller G; Dauta A; Desplanques M; Gareton A; Pages M; Tauziede-Espariat A; Grill J; Bourdeaut F; Doz F; Dhermain F; Mokhtari K; Chretien F; Figarella-Branger D; Varlet P
Neuro Oncol; 2020 Aug; 22(8):1190-1202. PubMed ID: 32025728
[TBL] [Abstract][Full Text] [Related]
43. Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor-Initiating Cells.
Mirzaei R; D'Mello C; Liu M; Nikolic A; Kumar M; Visser F; Bose P; Gallo M; Yong VW
Cancer Res; 2023 May; 83(10):1725-1741. PubMed ID: 37067922
[TBL] [Abstract][Full Text] [Related]
44. Vascular habitat analysis based on dynamic susceptibility contrast perfusion MRI predicts IDH mutation status and prognosis in high-grade gliomas.
Wu H; Tong H; Du X; Guo H; Ma Q; Zhang Y; Zhou X; Liu H; Wang S; Fang J; Zhang W
Eur Radiol; 2020 Jun; 30(6):3254-3265. PubMed ID: 32078014
[TBL] [Abstract][Full Text] [Related]
45. Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
Chandran UR; Luthra S; Santana-Santos L; Mao P; Kim SH; Minata M; Li J; Benos PV; DeWang M; Hu B; Cheng SY; Nakano I; Sobol RW
Genom Data; 2015 Sep; 5():333-336. PubMed ID: 26251826
[TBL] [Abstract][Full Text] [Related]
46. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
47. CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
Liu L; Yang Y; Duan H; He J; Sun L; Hu W; Zeng J
Front Oncol; 2021; 11():611038. PubMed ID: 33937022
[TBL] [Abstract][Full Text] [Related]
48. IDH1
Han X; Zhou H; Sun W; Hou L; Wang Y; Wang H; Lv Z; Xue X
Sci Rep; 2023 Nov; 13(1):19659. PubMed ID: 37952042
[TBL] [Abstract][Full Text] [Related]
49. Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant Glioma.
Spino M; Kurz SC; Chiriboga L; Serrano J; Zeck B; Sen N; Patel S; Shen G; Vasudevaraja V; Tsirigos A; Suryadevara CM; Frenster JD; Tateishi K; Wakimoto H; Jain R; Riina HA; Nicolaides TP; Sulman EP; Cahill DP; Golfinos JG; Isse K; Saunders LR; Zagzag D; Placantonakis DG; Snuderl M; Chi AS
Clin Cancer Res; 2019 Feb; 25(4):1261-1271. PubMed ID: 30397180
[TBL] [Abstract][Full Text] [Related]
50. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.
Herting CJ; Chen Z; Pitter KL; Szulzewsky F; Kaffes I; Kaluzova M; Park JC; Cimino PJ; Brennan C; Wang B; Hambardzumyan D
Glia; 2017 Dec; 65(12):1914-1926. PubMed ID: 28836293
[TBL] [Abstract][Full Text] [Related]
51. Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas.
Zeng W; Tang Z; Li Y; Yin G; Liu Z; Gao J; Chen Y; Chen F
Cancer Cell Int; 2020; 20():1. PubMed ID: 31908598
[TBL] [Abstract][Full Text] [Related]
52. Spatial Heterogeneity of Invading Glioblastoma Cells Regulated by Paracrine Factors.
Chonan Y; Yamashita T; Sampetrean O; Saya H; Sudo R
Tissue Eng Part A; 2022 Jul; 28(13-14):573-585. PubMed ID: 34841881
[TBL] [Abstract][Full Text] [Related]
53. SpaRx: Elucidate single-cell spatial heterogeneity of drug responses for personalized treatment.
Tang Z; Liu X; Li Z; Zhang T; Yang B; Su J; Song Q
bioRxiv; 2023 Aug; ():. PubMed ID: 37577665
[TBL] [Abstract][Full Text] [Related]
54. Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping.
Lyon JF; Vasudevaraja V; Mirchia K; Walker JM; Corona RJ; Chin LS; Tran I; Snuderl M; Richardson TE; Viapiano MS
Acta Neuropathol Commun; 2021 Jun; 9(1):120. PubMed ID: 34193272
[TBL] [Abstract][Full Text] [Related]
55. Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.
Nam Y; Koo H; Yang Y; Shin S; Zhu Z; Kim D; Cho HJ; Mu Q; Choi SW; Sa JK; Seo YJ; Kim Y; Lee K; Oh JW; Kwon YJ; Park WY; Kong DS; Seol HJ; Lee JI; Park CK; Lee HW; Yoon Y; Wang J
Genome Med; 2023 Mar; 15(1):16. PubMed ID: 36915208
[TBL] [Abstract][Full Text] [Related]
56. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
Mao P; Joshi K; Li J; Kim SH; Li P; Santana-Santos L; Luthra S; Chandran UR; Benos PV; Smith L; Wang M; Hu B; Cheng SY; Sobol RW; Nakano I
Proc Natl Acad Sci U S A; 2013 May; 110(21):8644-9. PubMed ID: 23650391
[TBL] [Abstract][Full Text] [Related]
57. Spatial Transcriptome-Wide Profiling of Small Cell Lung Cancer Reveals Intra-Tumoral Molecular and Subtype Heterogeneity.
Zhang Z; Sun X; Liu Y; Zhang Y; Yang Z; Dong J; Wang N; Ying J; Zhou M; Yang L
Adv Sci (Weinh); 2024 Jun; ():e2402716. PubMed ID: 38896789
[TBL] [Abstract][Full Text] [Related]
58. Ultra High-plex Spatial Proteogenomic Investigation of Giant Cell Glioblastoma Multiforme Immune Infiltrates Reveals Distinct Protein and RNA Expression Profiles.
Bonnett SA; Rosenbloom AB; Ong GT; Conner M; Rininger ABE; Newhouse D; New F; Phan CQ; Ilcisin S; Sato H; Lyssand JS; Geiss G; Beechem JM
Cancer Res Commun; 2023 May; 3(5):763-779. PubMed ID: 37377888
[TBL] [Abstract][Full Text] [Related]
59. Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma.
Han MZ; Wang S; Zhao WB; Ni SL; Yang N; Kong Y; Huang B; Chen AJ; Li XG; Wang J; Wang DH
EBioMedicine; 2019 May; 43():159-170. PubMed ID: 30987862
[TBL] [Abstract][Full Text] [Related]
60. Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology.
Mehani B; Asanigari S; Chung HJ; Dazelle K; Singh A; Hannenhalli S; Aldape K
Acta Neuropathol Commun; 2022 Feb; 10(1):19. PubMed ID: 35144680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
